Previous Article | Next Article ![]()
Journal of Virology, August 2005, p. 10498-10506, Vol. 79, No. 16
0022-538X/05/$08.00+0 doi:10.1128/JVI.79.16.10498-10506.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Wyeth Vaccines Research, Pearl River, New York 10965,1 Department of Biology, Indiana University-Purdue University Fort Wayne, Fort Wayne, Indiana 468052
Received 25 March 2005/ Accepted 4 May 2005
A herpes simplex virus type 2 (HSV-2) UL24 ß-glucuronidase (UL24-ßgluc) insertion mutant was derived from HSV-2 strain 186 via standard marker transfer techniques. Cell monolayers infected with UL24-ßgluc yielded cytopathic effect with syncytium formation. UL24-ßgluc replicated to wild-type viral titers in three different cell lines. UL24-ßgluc was not virulent after intravaginal inoculation of BALB/c mice in that all inoculated animals survived doses up to 400 times the 50% lethal dose (LD50) of the parental virus. Furthermore, few UL24-ßgluc-inoculated mice developed any vaginal lesions. Intravaginal inoculation of guinea pigs with UL24-ßgluc at a dose equivalent to the LD50 of parental virus (
5 x 103 PFU) was not lethal (10/10 animals survived). Although genital lesions developed in some UL24-ßgluc-inoculated guinea pigs, both the overall number of lesions and the severity of disease were far less than that observed for animals infected with parental strain 186.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»